TrialBlood advances2026
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.
Harinder Gill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it